Evolent Health, Inc. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a16a1bba-b86a-42f9-9926-35216cef5e97/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-410.1M | 2025-01-01 – 2025-12-31 | evidence 0001628908-26-000015 |
| FY 2024 | $-40.5M | 2024-01-01 – 2024-12-31 | evidence 0001628908-25-000020 |
| FY 2023 | $-71.2M | 2023-01-01 – 2023-12-31 | evidence 0001628908-24-000017 |
| FY 2022 | $3.6M | 2022-01-01 – 2022-12-31 | evidence 0001628908-23-000029 |
| FY 2021 | $-42.4M | 2021-01-01 – 2021-12-31 | evidence 0001628908-22-000027 |
| FY 2020 | $-262.8M | 2020-01-01 – 2020-12-31 | evidence 0001628908-23-000029 |
| FY 2019 | $-308.9M | 2019-01-01 – 2019-12-31 | evidence 0001628908-22-000027 |
| FY 2018 | $-47.5M | 2018-01-01 – 2018-12-31 | evidence 0001628908-19-000006 |
| FY 2017 | $-72.8M | 2017-01-01 – 2017-12-31 | evidence 0001628908-18-000015 |
| FY 2016 | $-237.4M | 2016-01-01 – 2016-12-31 | evidence 0001628908-17-000006 |
| FY 2015 | $-43.0M | 2015-01-01 – 2015-12-31 | evidence 0001628908-16-000030 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001628908-16-000030 |
| FY 2013 | $-21.2M | 2013-01-01 – 2013-12-31 | evidence 0001628908-16-000030 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).